Pharmaceuticals

Which Factors Will Push The Bioengineered Protein Drugs Market To Achieve $593.3 Billion By 2029?

September 23, 2025 by Marketing Posting

Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

#How Much Will The Bioengineered Protein Drugs Market Be Worth By 2029?#_x000D_

The market size for bioengineered protein drugs has evidenced substantial growth in the recent years. The market, originally valued at $406.39 billion in 2024, is projected to escalate to $435.17 billion in 2025. This represents a compound annual growth rate (CAGR) of 7.1%. The pronounced growth during the historic period is attributable to an enhanced comprehension of diseases, approvals from regulatory authorities, an increasing trend in chronic diseases, as well as collaborations, partnerships, and market expansion._x000D_

_x000D_

The marketplace for bioengineered protein drugs is expected to experience significant expansion in the coming years, with expected growth to $593.3 billion in 2029, at a compound annual growth rate (CAGR) of 8.1%. This projected growth during the forecast period can be credited to the increasing trends in personalized medicine, broader therapeutic applications, developing markets, concentration on rare diseases, and healthcare infrastructure advancements. Key trends expected to shape the forecast period include progression in protein engineering, heightened attention to monoclonal antibodies, personalized and targeted treatment approaches, the emergence of next-gen biologics, and the optimization of the manufacturing process._x000D_

_x000D_

#Get A Free Sample Of The Report:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=10180&type=smp_x000D_

_x000D_

#What Core Drivers Are Expected To Influence The Bioengineered Protein Drugs Market?#_x000D_

The escalating incidence of chronic conditions is predicted to fuel the expansion of the bioengineered protein drug industry. Chronic illnesses are defined as diseases that last for a year or more, necessitate ongoing medical attention, and limit day-to-day physical activities. Bioengineered protein drugs are employed in the treatment of chronic diseases, providing engineered protein therapies in oncology and regenerative medicine leveraging combinatorial and logical strategies. For example, as per the World Health Organization (WHO) 2022 Highlights, this intergovernmental health organization based in Switzerland recorded 41 million fatalities in September 2022, representing 74% of deaths attributed to noncommunicable diseases (NCDs) or chronic diseases annually. The global death toll includes 17.9 million from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Hence, the growth of chronic diseases is a significant driver for the bioengineered protein drugs market’s expansion._x000D_

_x000D_

#What Is The Segment Breakdown Of The Bioengineered Protein Drugs Market?#_x000D_

The bioengineered protein drugs market covered in this report is segmented – _x000D_

_x000D_

1) By Drug Type: Recombinant Protein, Vaccine, Peptide Antibiotics, Therapeutic Enzymes, Other Drug Type_x000D_

2) By Technology: Bioreactors, Fractionation, Genetically Modified Organisms, Genetic Engineering, Pharming, Cell Culture, Microbial Cell Fermentation, Other Technology_x000D_

3) By Application: Autoimmune, Heart, Congenital, Infectious Diseases, Cancer, Diabetes, Arthritis, Other Application_x000D_

4) By End User: Pharmaceutical, Contract Research Organizations, Research Institutes, Biotechnology Companies_x000D_

_x000D_

Subsegments:_x000D_

1) By Recombinant Protein: Monoclonal Antibodies, Hormones, Cytokines_x000D_

2) By Vaccine: Recombinant Vaccines, DNA Vaccines_x000D_

3) By Peptide Antibiotics: Lipopeptide Antibiotics, Glycopeptide Antibiotics_x000D_

4) By Therapeutic Enzymes: Enzyme Replacement Therapies, Biosimilar Enzymes_x000D_

5) By Other Drug Type: Fusion Proteins, Antibody-Drug Conjugates (ADCs)_x000D_

_x000D_

#How Are Global Trends Impacting The Development Of The Bioengineered Protein Drugs Market?#_x000D_

Prominent corporations in the bioengineered protein drug market are turning towards strategic partnerships strategies to supply crucial bioengineered protein drugs to companies, and government entities. Strategic alliances denote a method wherein businesses capitalize on one another’s skills and assets to reap reciprocal benefits and attain success. For instance, in June 2023, a Canada-based biotechnology corporation, Future Fields, formed a collaboration with another Canada-based biotechnology entity, Jenthera Therapeutics, which specializes in crafting novel therapy methods for rare and complicated ailments. Through this collaboration, they intend to create a unique protein to combat cancer, utilizing Future Fields’ EntoEngine platform for affordable and sustainable large-scale manufacture._x000D_

_x000D_

#Who Are The Major Stakeholders Operating In The Bioengineered Protein Drugs Market?#_x000D_

Major companies operating in the bioengineered protein drugs market include Abbvie Inc., Amgen Inc., Astrazeneca PLC, Bayer HealthCare Pharmaceuticals LLC, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Johnson & Johnson, Novartis AG, Novo Nordisk A/S, Sanofi S.A., Grifols S.A., Adma Biologics Inc., CSL Limited, Abbott Laboratories, Baxter International Inc., Fresenius Kabi AG, Merck & Co. Inc., Pfizer Inc., Biogen Inc., Bristol-Myers Squibb Company, Genentech Inc., Lonza Group AG, MedImmune LLC, Regeneron Pharmaceuticals Inc., Shire plc., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Shanghai United Cell Biotechnology Co. Ltd., Panacea Biotec Ltd. _x000D_

_x000D_

#Access The Complete Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/report/bioengineered-protein-drugs-global-market-report_x000D_

_x000D_

#Which Region Is Likely To Register The Fastest Growth In The Bioengineered Protein Drugs Market?#_x000D_

North America was the largest region in the bioengineered protein drugs market in 2024. The regions covered in the bioengineered protein drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#Customize Your Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=10180&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_